Loading clinical trials...
Loading clinical trials...
Evaluation of Dose Conversion From Variable Dosing Intervals of Darbepoetin Alfa to Variable Dosing Intervals of Epoetin Alfa in Patients With the Anemia of Chronic Kidney Disease
Conditions
Interventions
Epoetin alfa
Start Date
June 1, 2003
Completion Date
September 1, 2003
Last Updated
May 19, 2011
NCT05012111
NCT03520647
NCT05447442
NCT06287268
NCT04645199
NCT03050268
Lead Sponsor
Ortho Biotech Products, L.P.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions